Epithelium, microcirculation, and eosinophils – new aspects of the allergic airway in vivo
1997; Wiley; Volume: 52; Issue: 3 Linguagem: Inglês
10.1111/j.1398-9995.1997.tb00989.x
ISSN1398-9995
AutoresChrister Persson, Jonas S. Erjefält, Michael Andersson, I. Erjefält, Lennart Greiff, Magnus Korsgren, M Linden, F. Sundler, C. Svensson,
Tópico(s)Respiratory and Cough-Related Research
ResumoAllergyVolume 52, Issue 3 p. 241-255 Epithelium, microcirculation, and eosinophils – new aspects of the allergic airway in vivo C. G. A. Persson, Corresponding Author C. G. A. Persson Department of Clinical Pharmacology, University Hospital, LundCarl G. A. Persson, Department of Clinical Pharmacology University Hospital S-221 85 Lund SwedenSearch for more papers by this authorJ. S. Erjefält, J. S. Erjefält Department of Physiological Neuroscience, University of LundSearch for more papers by this authorM. Andersson, M. Andersson Department of Otorhinolaryngology, University Hospital, Lund, SwedenSearch for more papers by this authorI. Erjefält, I. Erjefält Department of Pharmacology and Cell Molecular Biology, Astra Draco, Lund, SwedenSearch for more papers by this authorL. Greiff, L. Greiff Department of Otorhinolaryngology, University Hospital, Lund, SwedenSearch for more papers by this authorM. Korsgren, M. Korsgren Department of Clinical Pharmacology, University Hospital, LundSearch for more papers by this authorM. Linden, M. Linden Department of Pharmacology and Cell Molecular Biology, Astra Draco, Lund, SwedenSearch for more papers by this authorF. Sundler, F. Sundler Department of Clinical Pharmacology, University Hospital, LundSearch for more papers by this authorC. Svensson, C. Svensson Department of Otorhinolaryngology, University Hospital, Lund, SwedenSearch for more papers by this author C. G. A. Persson, Corresponding Author C. G. A. Persson Department of Clinical Pharmacology, University Hospital, LundCarl G. A. Persson, Department of Clinical Pharmacology University Hospital S-221 85 Lund SwedenSearch for more papers by this authorJ. S. Erjefält, J. S. Erjefält Department of Physiological Neuroscience, University of LundSearch for more papers by this authorM. Andersson, M. Andersson Department of Otorhinolaryngology, University Hospital, Lund, SwedenSearch for more papers by this authorI. Erjefält, I. Erjefält Department of Pharmacology and Cell Molecular Biology, Astra Draco, Lund, SwedenSearch for more papers by this authorL. Greiff, L. Greiff Department of Otorhinolaryngology, University Hospital, Lund, SwedenSearch for more papers by this authorM. Korsgren, M. Korsgren Department of Clinical Pharmacology, University Hospital, LundSearch for more papers by this authorM. Linden, M. Linden Department of Pharmacology and Cell Molecular Biology, Astra Draco, Lund, SwedenSearch for more papers by this authorF. Sundler, F. Sundler Department of Clinical Pharmacology, University Hospital, LundSearch for more papers by this authorC. Svensson, C. Svensson Department of Otorhinolaryngology, University Hospital, Lund, SwedenSearch for more papers by this author First published: 29 April 2007 https://doi.org/10.1111/j.1398-9995.1997.tb00989.xCitations: 18AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Wurtman RJ, Bettiker RL. The slowing of treatment discovery, 1965–1995. Nature Med 1995; 1: 1122– 5. 2 Persson CGA. In vivo veritas. Thorax 1996; 51: 441– 3. 3 Paré PD. Conference summary. Chest 1995; 107: 163S– 9S. 4 SG Farmer, D Hay, editors. The airway epithelium. New York : Dekker, 1992. 5 Erjefält JS, Korsgren M, Nilsson MC, Sundler F, Persson CGA. Prompt epithelial damage- and restitution-processes in allergen challenged guinea-pig trachea. Clin Exp Allergy 1997 (in press). 6 Persson CGA. Airway epithelium and microcirculation. Eur Respir Rev 1994; 4: 352– 62. 7 Persson CGA, Andersson M, Greiff L, et al. Airway permeability. Clin Exp Allergy 1995; 23: 807– 14. 8 Greiff L, Wollmer P, Svensson C, Andersson M, Persson CGA. Effect of seasonal allergic rhinitis on airway mucosal absorption of chromium-51-labelled EDTA. Thorax 1993; 48: 648– 50. 9 Greiff L, Andersson M, Svensson C, Lundin S, Wollmer P, Persson CGA. Reduced airway absorption in seasonal allergic rhinitis. Am J Respir Crit Care Med 1997 (in press). 10 Houston JC, DeNavasques S, Trounce JR. A clinical and pathological study of fatal cases of status asthmaticus. Thorax 1953; 8: 207– 13. 11 Evans MJ, Plopper CG. The role of basal cells in adhesion of columnar epithelium to airway basement membrane. Am Rev Respir Dis 1988; 138: 481– 3. 12 Montefort S, Roberts JA, Beasly R, Holgate ST, Roche WR. The site of disruption of the bronchial epithelium in asthmatic and non-asthmatic subjects. Thorax 1992; 47: 499– 503. 13 Erjefält JS, Sundler F, Persson CGA. Epithelial barrier formation by airway basal cells. Thorax 1997 (in press). 14 Hilding AC. Regeneration of respiratory epithelium after minimal surface trauma. Ann Otol Rhinol Laryngol 1965: 74: 903– 14. 15 Lane BP, Gordon R. Regeneration of rat tracheal epithelium after mechanical injury. The relationship between mitotic activity and cellular differentiation. Proc Soc Exp Biol Med 1974; 145: 1139– 44. 16 Marin ML, Gordon RE, Lane BP. Development of tight junctions in rat tracheal epithelium during the early hours after mechanical injury. Am Rev Respir Dis 1979; 119: 101– 6. 17 Erjefält JS, Greiff L, Sundler F, Persson CGA. Basal cells promptly flatten out at detachment of the columnar epithelium in human and guinea-pig airways [Abstract]. Eur Respir J 1997 (in press). 18 Erjefält JS, Erjefält I, Sundler F, Persson CGA. In vivo restitution of airway epithelium. Cell Tissue Res 1995; 281: 305– 16. 19 Zahm JM, Chevillard M, Puchelle E. Wound repair of human surface respiratory epithelium. Am J Respir Cell Mol Biol 1991; 5: 242– 8. 20 Wilhelm DL. Regeneration of tracheal epithelium. J Pathol Bacteriol 1953; 95: 543– 50. 21 Shimizu T, Nishihara, Kawaguchi S, Sakakura Y. Expression of phenotypic markers during regeneration of rat tracheal epithelium following mechanical injury. Am J Respir Cell Mol Biol 1994: 11: 85– 94. 22 Erjefält JS, Erjefält I, Sundler F, Persson CGA. Micro-circulation-derived factors in epithelial repair. Microvasc Res 1994: 148: 161– 78. 23 Erjefält JS, Sundler F, Persson CGA. Eosinophils, neutrophils and venular gaps in the airway mucosa at epithelial removal-restitution. Am J Respir Crit Care Med 1996; 153: 1666– 74. 24 Erjefält JS, Sundler F, Persson CGA. Structural changes in the airways after acute and repeated epithelial denudation in vivo. Am Rev Respir Crit Care Med 1995: 151: 698. 25 Persson CGA, Erjefält JS, Erjefält I, Korsgren M, Nilsson M, Sundler F. Epithelial shedding-restitution as a causative process in airway inflammation. J Clin Exp Allergy 1996; 26: 746– 55. 26 Erjefält JS, Erjefält I, Sundler F, Persson CGA. Effects of topical budesonide on epithelial restitution in vivo in guinea-pig trachea. Thorax 1995: 50: 785– 92. 27 Lundgren R, Söderberg M, Hörstedt P, Stenling R. Morphological studies of bronchial mucosal biopsies from asthmatics before and after ten years of treatment with inhaled steroids. Eur Respir J 1988; 1: 883– 9. 28 Laitinen LA, Laitinen A, Haahtela T. A comparative study of the effects of an inhaled corticosteroid, budesonide, and a β2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial. J Allergy Clin Immunol 1992: 90: 34– 42. 29 Persson CGA. Epithelial cells: barrier functions and shedding-restitution mechanisms. In: PJ Barnes, A Woolcock, editors. Asthma: the important questions. III. Am J Respir Crit Care Med 1996; 153: 9S– 10S. 30 Iwama T, Nagai H, Suda H, Tsuruoka N, Koda A. Effect of murine recombinant interleukin-5 on the cell population in guinea-pig airways. Br J Pharmacol 1992; 105: 19– 22. 31 S Brain, editor. Immunopharmacology of the micro-vasculature. London : Academic Press, 1994. 32 LA Laitinen, RO Salonen, JG Widdicombe, editors. Tracheobronchial and nasal circulation. Eur Respir J 1990: 3 Suppl 12. 33 McDonald DM. Endothelial gaps and permeability of venules in rat tracheas exposed to inflammatory stimuli. Am J Physiol 1994; 266: L61– 83. 34 Persson CGA, Svensson C, Greiff L, et al. Editorial. The use of the nose to study the inflammatory response of the respiratory tract. Thorax 1992: 47: 993– 1000. 35 Persson CGA, Erjefält I. Inflammatory leakage of macro-molecules from the vascular compartment into the tracheal lumen. Acta Physiol Scand 1986: 126: 615– 16. 36 Erjefält I, Persson CGA. Inflammatory passage of plasma macromolecules into airway tissue and lumen. Pulm Pharmacol 1989: 2: 93– 102. 37 Erjefält I, Persson CGA. Allergen, bradykinin, and capsaicin increase outward but not inward macromolecular permeability of guinea-pig tracheobronchial mucosa. Clin Exp Allergy 1991: 21: 217– 24. 38 Greiff L, Erjefält I, Wollmer P, Pipkorn U, Persson CGA. Effects of histamine, ethanol, and a detergent on exudation and absorption across guinea pig airways mucosa in vivo. Thorax 1991: 46: 700– 5. 39 Greiff L, Wollmer P, Pipkorn U, Persson CGA. Absorption of 51Cr EDTA across the human nasal airway barriers in the presence of topical histamine. Thorax 1991: 46: 630– 2. 40 Persson CGA, Erjefält I, Alkner U, et al. Plasma exudation as a first line respiratory mucosal defence. Clin Exp Allergy 1991: 21: 17– 24. 41 Erjefält JS, Erjefält I, Sundler F, Persson CGA. Epithelial pathways for luminal entry of bulk plasma. Clin Exp Allergy 1995: 25: 187– 95. 42 Luts A, Sundler F, Erjefält I, Persson CGA. The airway epithelial lining is intact promptly after the mucosal crossing of a large amount of plasma exudate. Int Arch Allergy Appl Immunol 1990: 91: 385– 9. 43 Salomonsson P, Grönneberg R, Gilljam H, et al. Bronchial exudation of bulk plasma at allergen challenge in allergic asthma. Am Rev Respir Dis 1992; 146: 1535– 42. 44 Svensson C, Grönneberg R, Andersson M, et al. Allergen challenge-induced entry of alpha-2-macrogIobulin and tryptase into human nasal and bronchial airways. J Allergy Clin Immunol 1995: 96: 239– 46. 45 Persson CGA. Plasma exudation from tracheobronchial microvessels in health and disease. In: J Butler, editor. The bronchial circulation. New York : Dekker, 1992: 443– 73. 46 Fahy JV, Liu J, Wong H, Boushey HA. Cellular and biochemical analysis of induced sputum from asthmatic and healthy individuals. Am Rev Respir Dis 1993: 147: 1126– 31. 47 Pizzichini E, Pizzichini MMM, Efthimiadis A, et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996: 154: 308– 17. 48 Berman AR, Liu MC, Wagner EM, Proud D. Dissociation of bradykinin-induced plasma exudation and reactivity in the peripheral airways. Am J Respir Crit Care Med 1996: 154: 418– 23. 49 Greiff L, Alkner U, Pipkorn U, Persson CGA. The “nasal pool” device applies controlled concentrations of solutes on human nasal airway mucosa and samples its surface exudations/secretions. Clin Exp Allergy 1990; 20: 253– 9. 50 Erjefält I, Luts A, Persson CGA. Appearance of airway absorption and exudation tracers in guinea-pig tracheobronchial lymph nodes. J Appl Physiol 1993: 74: 817– 24. 51 Persson CGA, Erjefält I, Gustafsson B, Luts A. Subepithelial hydrostatic pressure may regulate plasma exudation across the mucosa. Int Arch Allergy Appl Immunol 1990; 92: 148– 53. 52 Gustafsson BG, Persson CGA. Asymmetrical effects of increases in hydrostatic pressure on macromolecular movement across the airway mucosa. A study in guinea-pig tracheal tube preparation. Clin Exp Allergy 1991; 21: 121– 6. 53 Kondo M, Finkbeiner WE, Widdicombe JH. Changes in permeability of dog tracheal epithelium in response to hydrostatic pressure. Am J Physiol 1992; 262: L176– 82. 54 Tang L, Eaton JW. Fibrin(ogen) mediates acute inflammatory responses to biomaterials. J Exp Med 1993; 178: 2147– 56. 55 Erjefält JS, Korsgren M, Nilsson MC, Sundler F, Persson CGA. Association between inflammation and epithelial damage-restitution processes in allergic airways in vivo. Clin Exp Allergy 1997 (in press). 56 Gray AJ, Reeves JT, Harrison NK, Winlove P, Laurent GJ. Growth factors for human fibroblasts in the solute remaining after clot formation. J Cell Sci 1990; 96: 271– 4. 57 Grainger DJ, Kemp PR, Metcalfe JC, et al. The serum concentration of active transforming growth factor-B is severely depressed in advanced atherosclerosis. Nature Med 1995; 1: 74– 9. 58 W Borth, RD Feinman, SL Gonias, JP Quigley, DK Strickland, editors. Biology of α-macroglobulin, its receptor, and related proteins. New York : New York Academy of Science, 1994. 59 Svensson C, Greiff L, Andersson M, Alkner U, Grönneberg R, Persson CGA. Antiallergic actions of high topical doses of terbutaline in human nasal airways. Allergy 1995; 50: 884– 90. 60 Persson CGA, Alkner U, Andersson M, Greiff L, Linden M, Svensson C. Histamine challenge-induced “lamina propria lavage” and mucosal output of IL-6 in human airways. Eur Respir J 1995; 8 Suppl 19: 125s. 61 Greiff L, Andersson E, Andersson M, et al. Mucosal output of α2-macroglobulin and ECP in children with seasonal allergic rhinitis [Abstract]. Am J Respir Crit Care Med 1997 (in press). 62 Persson CGA, Erjefält JS, Andersson M, Greiff L, Svensson C. Extravasation, lamina propria flooding and lumenal entry of bulk plasma exudate in mucosal defence, inflammation and repair. Pulm Pharmacol 1996; 9: 129– 39. 63 Curschmann H. Über Bronchiolitis exsudativa und ihr Verhältniss zum Asthma nervosum. Dtsch Arch Klin Med 1883; 32: 1– 34. 64 Erjefält I, Persson CGA. Pharmacological control of plasma exudation into tracheobronchial airways. Am Rev Respir Dis 1991; 143: 1008– 14. 65 Persson CGA. Xanthines as airway anti-inflammatory drugs. J Allergy Clin Immunol 1988; 81: 615– 17. 66 Persson CGA. Cromoglycate, plasma exudation and asthma. Trends Pharmacol Sci 1987; 8: 202– 3. 67 Persson CGA. A cornucopia of drug discovery Nature Med 1996; 2: 5– 6. 68 Persson CGA. Plasma exudation and asthma. Lung 1988; 166: 1– 23. 69 Svensson C, Klementsson H, Andersson M, Pipkorn U, Alkner U, Persson CGA. Glucocorticoid-reduced attenuation of mucosal exudation of bradykinins and fibrinogen in seasonal allergic rhinitis. Allergy 1994; 49: 177– 83. 70 van de Graaf EA, Out TA, Roos CM, Jansen HM. Respiratory membrane permeability and bronchial hyper-reactivity in patients with stable asthma. Effects of therapy with inhaled steroids. Am Rev Respir Dis 1991; 143: 362– 8. 71 Greiff L, Andersson M, Svensson C, Alkner U, Persson CGA. Glucocorticoids may not inhibit plasma exudation by direct vascular antipermeability effects in human airways. Eur Respir J 1994: 7: 1120– 4. 72 Greiff L, Andersson M, Svensson C, Åkerlund A, Alkner U, Persson CGA. Effects of two weeks' topical budesonide treatment on microvascular exudative responsiveness in healthy human nasal airways. Eur Respir J 1997 (in press). 73 Farr BM, Gwaltney JM Jr, Hendley JO. A randomized controlled trial of glucocorticoid prophylaxis against experimental rhinovirus infection. J Infect Dis 1990; 162: 1173– 7. 74 Erjefält I, Persson CGA. Increased sensitivity to toluene diisocyanate (TDI) in airways previously exposed to low doses of TDI. Clin Exp Allergy 1992: 22: 854– 62. 75 RP Schleimer, W Busse, P O'Byrne, editors. Topical glucocorticoids in asthma – mechanisms and clinical action. New York : Dekker, 1996. 76 Greiff L, Erjefält I, Wollmer P, et al. Effects of nicotine on the human nasal airway mucosa. Thorax 1993; 48: 651– 5. 77 Greiff L, Svensson C, Andersson M, Persson CGA. Effects of topical capsaicin in seasonal allergic rhinitis. Thorax 1995: 50: 225– 9. 78 Haldursdottir H, Greiff L, Wollmer P, et al. Inhaled histamine, but not inhaled capsaicin, evokes acute exudation of α2-macroglobulin into human bronchi. Am J Respir Crit Care Med 1996; 153: A290. 79 GJ Gleich, AB Kay, editors. Eosinophils in allergy and inflammation. New York : Dekker, 1994: i– xxxiv, 1–496. 80 Simon H-U, Blaser K. Inhibition of programmed eosinophil death: a key pathogenic event for eosinophilia Immunol Today 1995; 16: 53– 5. 81 Cox G, Ohtoshi T, Vancheri C, et al. Promotion of eosinophil survival by human bronchial epithelial cells and its modulation by steroids. Am J Respir Cell Mol Biol 1991: 4: 525– 31. 82 Schleimer RP, Bochner BS. The effects of glucocorticoids on human eosinophils. J Allergy Clin Immunol 1994: 94: 1202– 13. 83 Duvall E, Wyllie AH. Death and the cell. Immunol Today 1986: 7: 115– 19. 84 Majno G, Joris J. Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 1995: 146: 3– 15. 85 Persson CGA, Erjefält JS. Eosinophil lysis and free eosinophil granules: an in vivo paradigm for cell activation and drug development. Review. TiPS 1997 (in press). 86 Griffiths-Johnson DA, Collins PD, Rossi AG, Jose PJ, Williams TJ. The chemokine, eotaxin, activates guinea-pig eosinophils in vitro and causes their accumulation in the lung in vivo. Biochem Biophys Res Commun 1993; 197: 1167– 72. 87 Korsgren M, Erjefält JS, Erjefält I, Sundler F, Persson CGA. Eotaxin may regulate homing of eosinophils to airway epithelium: immunocytochemical and in situ hybridization studies in naive and allergen challenged guinea-pigs [Abstract]. Am J Respir Crit Care Med 1997 (in press). 88 Jeffery PK, Godfrey RW, Ädelroth E, Nelson F, Rogers A, Johansson, S-Å. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. Am Rev Respir Dis 1992; 145: 890– 9. 89 Filley WV, Kephart GM, Holley KE, Gleich GJ. Identification by immunofluorescence of eosinophil granule major basic protein in lung tissues of patients with bronchial asthma. Lancet 1982; 2: 11– 16. 90 Ohashi Y, Motojima S, Fukuda T, Makino S. Airway hyperresponsiveness, increased intracellular spaces of bronchial epithelium, and increased infiltration of eosinophils and lymphocytes in bronchial mucosa in asthma. Am Rev Respir Dis 1992: 145: 1469– 76. 91 Beasley R, Roche WR, Roberts JA, Holgate ST. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 1989: 139: 806– 17. 92 Erjefält JS, Greiff L, Andersson M, Svensson C, Persson CGA. Eosinophil lysis and clusters of free eosinophil granules (Cfegs) in rhinitis and asthma [Abstract]. Am J Respir Crit Care Med 1997 (in press). 93 Gundel RH, Gerritsen ME, Gleich GJ, Wegner CD. Repeated antigen inhalation results in a prolonged airway eosinophilia and airway hyperresponsiveness in primates. J Appl Physiol 1990; 68: 779– 86. 94 Korsgren M, Erjefält JS, Erjefält I, Sundler F, Persson CGA. Allergen challenge-induced occurrence of eosinophils and clusters of free eosinophil granules (Cfegs) in tracheobronchial lymph nodes of sensitized guinea-pigs [Abstract]. Am J Respir Crit Care Med 1997 (in press). 95 Dvorak AM, Weller PF, Monahan-Earley RA, Letourneau L, Ackerman SJ. Ultrastructural localisation of Charcot-Leyden crystal protein (lysophospholipase) and peroxidase in macrophages, eosinophils, and extracellular matrix of the skin in the hypereosinophilic syndrome. Lab Invest 1990; 590– 607. 96 Seiler G, Westerman RA, Wilson JA. The role of specific eosinophil granules in eosinophil-induced experimental encephalitis. Neurology 1969: 19: 478– 88. 97 Erjefält JS, Korsgren M, Gustafsson B, Sonmark B, Andersson P, Persson CGA. Eosinophils and epithelial-vascular changes in airways and lungs of allergic mice [Abstract]. Am J Respir Crit Care Med 1997 (in press). 98 Korsgren M, Erjefält JS, Korsgren O, Sundler F, Persson CGA. Allergic, eosinophil-rich inflammation develops in lungs-airways of B cell-deficient mice. J Exp Med 1997 (in press). Citing Literature Volume52, Issue3March 1997Pages 241-255 ReferencesRelatedInformation
Referência(s)